Thymoma treatment study pulled before enrolling a single patient
NCT ID NCT02633514
First seen Apr 29, 2026 · Last updated May 29, 2026 · Updated 4 times
Summary
This study was designed to see if adding chemotherapy to radiation therapy helps people with thymoma or thymic cancer live longer after incomplete tumor removal. It planned to include adults aged 18-75 who had surgery but still had some cancer left. However, the study was withdrawn before any participants were enrolled, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THYMOMA AND THYMIC CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Kailiang Wu
Shanghai, Shanghai Municipality, 20032, China
Conditions
Explore the condition pages connected to this study.